GenSight Biologics SA's market cap is currently €23.14M. The company's EPS TTM is €-0.076; its P/E ratio is ―; GenSight Biologics SA is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in EUR
GenSight Biologics SA Earnings and Revenue History
